Isolation of a human prostate carcinoma cell line (DU 145)
✍ Scribed by Kenneth R. Stone; Don D. Mickey; Heidi Wunderli; George H. Mickey; David F. Paulson
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- French
- Weight
- 943 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A long‐term tissue culture cell line has been derived from a human prostate adenocarcinoma metastatic to the brain. The cell line, DU 145, has been passaged 90 times in vitro over a period of 2 years. The cells are epithelial, grow in isolated islands on plastic Petri dishes, and form colonies in soft agar suspension culture. Karyotypic analysis demonstrates an aneuploid human karyotype with a modal chromosome number of 64. Distinctive marker chromosomes (a translocation Y chromosome, metacentric minute chromosomes and three large acrocentic chromosomes) have been identified. Electron microscopy of the original tumor tissue and of the tissue culture cell line show a remarkable similarity in cell organelle structure.
📜 SIMILAR VOLUMES
## Abstract Prostate carcinoma is one of the most common malignant tumors and has become a more common cancer in men. Previous studies demonstrated that evodiamine (EVO) exhibited anti‐tumor activities on several cancers, but its effects on androgen‐independent prostate cancer are unclear. In the p
Two human prostate carcinoma cell lines are easily distinguished by C-banding. DU 145 has one metacentric chromosome with a large centromeric band, I metacentric and 2 acrocentric chromosomes with interstitial C-bands. The Y chromosome was present in 48% and 42% of the cells at passages 83 and 106,
## Background: Recent studies suggest that the gene for manganese superoxide dismutase (mnsod) is a candidate tumor-suppressor gene. the present study was designed to study the effect of overexpression of mnsod on cultured human prostate carcinoma cells. ## Methods: Du145 human prostate carcinoma
## Abstract Development of effective agents for treatment of hormone‐refractory prostate cancer has become a national medical priority. We have reported recently that apigenin (4′,5,7‐trihydroxyflavone), found in many common fruits and vegetables, has shown remarkable effects in inhibiting cell gro